Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer

Fig. 1

Cytotoxic effects of troglitazone (TGZ) and pioglitazone (PGZ) in two pancreatic cancer cell lines. MIA Paca2 or PANC-1 cells were pre-cultured for 24Ā h at a density of 1ā€‰Ć—ā€‰104 cells/well in 96-well plates and treated with TGZ or PGZ for 24Ā h. Cell viability was assessed by fluorescence assay, and data represent the meanā€‰Ā±ā€‰SD from four independent preparations. Statistical significance was assessed by Dunnettā€™s test (control vs. each concentration of TGZ). * pā€‰<ā€‰0.05 and ** pā€‰<ā€‰0.01 vs. control (for TGZ). ā€  pā€‰<ā€‰0.05 and ā€ ā€  pā€‰<ā€‰0.01 vs. control (for PGZ)

Back to article page